Close

Dyax Corp (DYAX) PT Raised to $16 at BofA/Merrill Lynch Following EU Physician Survey

December 4, 2014 7:31 AM EST Send to a Friend
BofA/Merrill Lynch analyst Tazeen Ahmad reiterated a Buy rating and boosted her price target on Dyax Corp. (NASDAQ: DYAX) to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login